Galventa AG is a Swiss life science company founded in 2018, developing patented galenic formulations with unique release profiles and bioavailability for nutraceutical and OTC products. The company's flagship brand is B SYNC, a delayed-release wake-up capsule. Galventa develops and licenses formulation technology but does not appear to offer contract manufacturing services to third parties.
Patented galenic formulations, delayed-release technology, sublingual delivery, nutraceutical formulation, clinical validation
1 site worldwide
No certifications on file yet.
No reviews available yet.
No documents available.